13F filer · CIK 923093 ↗
Tudor Investment
You are looking at Q3 2019. See the latest, Q2 2026 →
Reported value
$2.91B
−17% on the quarter before
Positions
1,049
424 new · 439 sold out
Top 10
28.0%
of the value
Est. gain
−$15.0M
on stocks held all quarter
Est. return
−1.3%
on those stocks since Q2 2019
Positions as of Sep 30, 2019, from Tudor Investment's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 36% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2019. Striped tiles are options.
Largest buys
Since Q2 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- SPDR S&P 500 ETF Trust~$64.3MAdded · 0.1% → 2.3%+216,702 shares
- Allergan Plc~$50.1MAdded · 1.3% → 3.2%+297,584 shares
- Suntrust Banks Inc~$48.5MAdded · 1.9% → 4.1%+704,644 shares
- Alder Biopharmaceuticals IncPUT~$28.3MNew · 0.0% → 1.0%+1,503,000 underlying
- United Financial Bancorp Inc/New~$22.2MNew · 0.0% → 0.8%+1,631,735 shares
- Alder Biopharmaceuticals Inc~$20.5MAdded · 0.0% → 0.7%+1,089,040 shares
- Celgene Corporation~$17.1MAdded · 3.0% → 4.4%+172,000 shares
- Public Storage~$14.9MNew · 0.0% → 0.5%+60,929 shares
- Starbucks Corporation~$12.7MAdded · 0.1% → 0.5%+143,773 shares
- Marriott International-Cl A~$12.5MNew · 0.0% → 0.4%+100,387 shares
Largest sells
Since Q2 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- SPDR S&P 500 ETF TrustPUT~$465.0MCut · 19.1% → 7.4%−1,566,900 underlying
- Ishares Msci Emerging Markets - ETF~$211.3MCut · 6.6% → 0.3%−5,169,851 shares
- SPDR S&P 500 ETF TrustCALL~$86.7MCut · 3.5% → 1.3%−292,100 underlying
- Anadarko Petroleum Corporation~$64.3MSold out · 1.8% → 0.0%−911,118 shares
- Worldpay Inc - Cl A~$60.0MSold out · 1.7% → 0.0%−489,482 shares
- Tableau Software Inc-Cl A~$52.1MSold out · 1.5% → 0.0%−313,800 shares
- Ishares Jp Morgan Usd Emerging Markets Bond ETF~$32.2MSold out · 0.9% → 0.0%−284,000 shares
- Cray Inc.~$22.7MSold out · 0.6% → 0.0%−650,534 shares
- Array Biopharma Inc~$17.2MSold out · 0.5% → 0.0%−371,306 shares
- Aratana Therapeutics Inc~$16.4MSold out · 0.5% → 0.0%−3,179,912 shares
Holdings
As of Sep 30, 2019. Changes are in shares against Jun 30, 2019, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SPDR S&P 500 ETF TrustPUTCOMMON STOCK · shares −68% | 7.4% | $215.4M | — | ||||||||
| Celgene CorporationCOMMON STOCK · shares +15% · price +7.4% | 4.4% | $128.4M | +$7.7M | ||||||||
| Suntrust Banks IncCOMMON STOCK · shares +68% · price +9.5% | 4.1% | $120.3M | +$6.2M | ||||||||
| Allergan PlcCOMMON STOCK · shares +113% · price +0.5% | 3.2% | $94.5M | +$227,501 | ||||||||
| SPDR S&P 500 ETF TrustCOMMON STOCK · shares +2,248% · price +1.3% | 2.3% | $67.2M | +$36,168 | ||||||||
| Celgene CorporationPUTCOMMON STOCK · shares −9.8% | 1.5% | $44.0M | — | ||||||||
| Walt Disney Company (The)COMMON STOCK · shares +22% · price −6.7% | 1.5% | $42.9M | −$2.5M | ||||||||
| MicrosoftCOMMON STOCK · shares +9.4% · price +3.8% | 1.3% | $38.9M | +$1.3M | ||||||||
| SPDR S&P 500 ETF TrustCALLCOMMON STOCK · shares −70% | 1.3% | $37.4M | — | ||||||||
| Alder Biopharmaceuticals IncPUTCOMMON STOCK · shares New | 0.97% | $28.3M | — | ||||||||
| United Financial Bancorp Inc/NewCOMMON STOCK · shares New | 0.76% | $22.2M | — | ||||||||
| Alder Biopharmaceuticals IncCOMMON STOCK · shares +4,136% · price +60.2% | 0.72% | $21.0M | +$186,605 | ||||||||
| AmazonCOMMON STOCK · shares +47% · price −8.3% | 0.66% | $19.2M | −$1.2M | ||||||||
| ServiceNowCOMMON STOCK · shares +87% · price −7.5% | 0.65% | $19.0M | −$831,021 | ||||||||
| Alteryx Llc - ACOMMON STOCK · shares +184% · price −1.6% | 0.65% | $19.0M | −$105,439 | ||||||||
| Ishares Tips Bond ETFCOMMON STOCK · shares −2.7% · price +0.7% | 0.60% | $17.5M | +$120,484 | ||||||||
| OracleCOMMON STOCK · shares +189% · price −3.4% | 0.57% | $16.6M | −$202,351 | ||||||||
| United Healthcare GroupCOMMON STOCK · shares +216% · price −10.9% | 0.52% | $15.0M | −$583,948 | ||||||||
| Public StorageCOMMON STOCK · shares New | 0.51% | $14.9M | — | ||||||||
| Starbucks CorporationCOMMON STOCK · shares +575% · price +5.5% | 0.51% | $14.9M | +$115,189 | ||||||||
| Extra Space Storage IncCOMMON STOCK · shares +573% · price +10.1% | 0.50% | $14.5M | +$197,509 | ||||||||
| Atlassian Corp Plc-Class ACOMMON STOCK · shares +605% · price −4.1% | 0.48% | $14.1M | −$85,796 | ||||||||
| Zendesk IncCOMMON STOCK · shares +105% · price −18.1% | 0.45% | $13.1M | −$1.4M | ||||||||
| Citizens Financial GroupCOMMON STOCK · shares +586% · price +0.1% | 0.44% | $12.8M | +$947.57 | ||||||||
| Cme Group IncCOMMON STOCK · shares 0% · price +8.9% | 0.44% | $12.7M | +$1.0M | ||||||||
| Total · 1,049 positions | 100% | $2.91B | −$15.0M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2019 to Q3 2019: 619 stocks held throughout, down $15.0M (−1.3%).
- Celgene Corporation+$7.7M+7%
- Suntrust Banks Inc+$6.2M+9%
- Microsoft+$1.3M+4%
- Inphi Corp+$1.2M+22%
- Lam Research+$1.1M+23%
- Zendesk Inc−$1.4M−18%
- Alexion Pharmaceuticals Incorporated−$2.0M−25%
- Align Technology Inc−$2.2M−34%
- Walt Disney Company (The)−$2.5M−7%
- Slack Technologies Inc- Cl A−$3.4M−37%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 3 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $71.91B+33% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $53.87B−0% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $54.03B−7% | SEC ↗ |
| Q3 2025 | Dec 9, 2025 (amended) | $57.98B+26% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $45.92B+53% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $30.10B+15% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $26.28B−4% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $27.48B+41% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $19.52B+24% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $15.72B+27% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $12.42B+25% | SEC ↗ |
| Q3 2023 | Nov 15, 2023 | $9.97B+19% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $8.38B+30% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $6.46B+28% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $5.06B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $4.63B+22% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $3.81B−11% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $4.27B−29% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $5.98B−3% | SEC ↗ |
| Q3 2021 | Nov 17, 2021 (amended) | $6.16B+16% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $5.29B+6% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $4.99B+41% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $3.54B+54% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $2.30B+14% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $2.02B+81% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $1.12B−50% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $2.23B−23% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $2.91B−17% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $3.51B+45% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $2.42B−52% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $5.06B+27% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $3.98B+38% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $2.87B−7% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $3.09B−22% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $3.94B+0% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $3.92B+19% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $3.28B+1% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $3.25B−16% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $3.88B−9% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $4.27B−10% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $4.72B+21% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $3.91B | SEC ↗ |